Gene · 1808
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering the Tubulin Language: Molecular Determinants and Readout Mechanisms of the Tubulin Code in Neurons. | Int J Mol Sci | 2023 | 36769099 | PubTator, text mining | PubMed |
| Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy. | Int J Mol Sci | 2023 | 36768153 | PubTator, text mining | PubMed |
| Maternal brain reactive antibodies profile in autism spectrum disorder: an update. | Transl Psychiatry | 2023 | 36737600 | PubTator, text mining | PubMed |
| Antibody Profiling and In Silico Functional Analysis of Differentially Reactive Antibody Signatures of Glioblastomas and Meningiomas. | Int J Mol Sci | 2023 | 36674927 | PubTator, text mining | PubMed |
| Comparing the Biology of Young versus Old Age Estrogen-Receptor-Positive Breast Cancer through Gene and Protein Expression Analyses. | Biomedicines | 2023 | 36672708 | PubTator, text mining | PubMed |
| The Multitasker Protein: A Look at the Multiple Capabilities of NUMB. | Cells | 2023 | 36672267 | PubTator, text mining | PubMed |
| Chronic MAP4343 reverses escalated alcohol drinking in a mouse model of alcohol use disorder. | Neuropsychopharmacology | 2023 | 36670228 | PubTator, text mining | PubMed |
| [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. | Nat Med | 2023 | 36646800 | PubTator, text mining | PubMed |
| Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia. | Cancer Med | 2023 | 36621846 | PubTator, text mining | PubMed |
| A central CRMP complex essential for invasion in Toxoplasma gondii. | PLoS Biol | 2023 | 36602948 | PubTator, text mining | PubMed |
The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders. | IBRO Neurosci Rep | 2023 | 36590248 | PubTator, text mining | PubMed |
| The fates of internalized NaV1.7 channels in sensory neurons: Retrograde cotransport with other ion channels, axon-specific recycling, and degradation. | J Biol Chem | 2023 | 36539035 | PubTator, text mining | PubMed |
| Data-driven analysis and druggability assessment methods to accelerate the identification of novel cancer targets. | Comput Struct Biotechnol J | 2023 | 36514341 | PubTator, text mining | PubMed |
| Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth. | J Biol Chem | 2023 | 36470425 | PubTator, text mining | PubMed |
| A cryo-electron microscopic approach to elucidate protein structures from human brain microsomes. | Life Sci Alliance | 2023 | 36450447 | PubTator, text mining | PubMed |
| Guillain-Barré Syndrome Following Zika Virus Infection Is Associated With a Diverse Spectrum of Peripheral Nerve Reactive Antibodies. | Neurol Neuroimmunol Neuroinflamm | 2023 | 36411078 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Novel insights into the mechanism of reactive oxygen species-mediated neurodegeneration. | Neural Regen Res | 2023 | 36204830 | PubTator, text mining | PubMed |
| Neuropharmacology of Alcohol Addiction with Special Emphasis on Proteomic Approaches for Identification of Novel Therapeutic Targets. | Curr Neuropharmacol | 2023 | 35959616 | PubTator, text mining | PubMed |
| Efficacy and safety of probiotics in Parkinson's constipation: A systematic review and meta-analysis. | Front Pharmacol | 2022 | 36703760 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1808/papers?page=10